<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        223-186-04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        JULMENTIN 600MG INJ.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Parenteral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        67.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Julmentin </strong>is an antibiotic and works by killing bacteria that cause infections.<strong> </strong>It contains two different medicines called amoxicillin and clavulanic acid.</p><p>Amoxicillin belongs to a group of medicines called &ldquo;penicillins&rdquo; that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening.</p><p><strong>Julmentin is used in adults and children to treat the following infections:</strong></p><p>&middot;&nbsp; &nbsp;severe ear, nose and throat infections</p><p>&middot;&nbsp; respiratory tract infections</p><p>&middot;&nbsp; urinary tract infections</p><p>&middot;&nbsp; &nbsp;skin and soft tissue infections including dental infections</p><p>&middot;&nbsp; &nbsp;bone and joint infections</p><p>&middot;&nbsp; &nbsp;intra-abdominal infections</p><p>&middot;&nbsp; genital organ infections in women.</p><p><strong>Julmentin </strong>is used in adults and children to prevent infections associated with major surgical procedures.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>You should not have Julmentin:</strong></p><p>&middot;&nbsp; if you are allergic to amoxicillin, clavulanic acid, penicillin or any of the other ingredients of this medicine (listed in section 6)</p><p>&middot;&nbsp; if you have ever had a severe allergic (hypersensitive) reaction to any other antibiotic. This can include a skin rash or swelling of the face or neck</p><p>&middot;&nbsp; if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic.</p><p><strong>Do not take Julmentin if any of the above applies to you.</strong> If you are not sure, talk to your doctor, pharmacist or nurse before having <strong>Julmentin</strong>.</p><p><strong>Take special care with Julmentin </strong></p><p>Talk to your doctor or pharmacist or nurse before having <strong>Julmentin </strong>if you:</p><p>&middot;&nbsp; have glandular fever</p><p>&middot;&nbsp; are being treated for liver or kidney problems</p><p>&middot;&nbsp; are not passing water regularly.</p><p>If you are not sure if any of the above apply to you, talk to your doctor, pharmacist or nurse before taking <strong>Julmentin</strong>.</p><p>In some cases, your doctor may investigate the type of bacteria that is causing your infection. Depending on the results, you may be given a different strength of <strong>Julmentin </strong>or a different medicine.</p><p><strong>Conditions you need to look out for</strong></p><p><strong>Julmentin </strong>can make some existing conditions worse, or cause serious side effects. These include allergic reactions, convulsions (fits) and inflammation of the large intestine. You must look out for certain symptoms while you are taking <strong>Julmentin</strong>, to reduce the risk of any problems. See &lsquo;Conditions you need to look out for&rsquo; in <strong>section 4.</strong></p><p><strong>Blood and urine tests</strong></p><p>If you are having blood tests (such as red blood cell status tests or liver function tests) or urine tests (for glucose), let the doctor or nurse know that you are taking <strong>Julmentin</strong>. This is because <strong>Julmentin </strong>can affect the results of these types of tests.</p><p><strong>Other medicines and Julmentin </strong></p><p>Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines. This includes medicines that can be bought without a prescription and herbal medicines.</p><p>&middot;&nbsp; If you are taking allopurinol (used for gout) with <strong>Julmentin</strong>, it may be more likely that you&rsquo;ll have an allergic skin reaction.</p><p>&middot;&nbsp; If you are taking probenecid (used for gout), your doctor may decide to adjust your dose of <strong>Julmentin </strong>.</p><p>&middot;&nbsp; If medicines to help stop blood clots (such as warfarin) are taken with <strong>Julmentin </strong>then extra blood tests may be needed.</p><p>&middot;&nbsp; <strong>Julmentin </strong>can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.</p><p>&middot;&nbsp; <strong>Julmentin </strong>can affect how mycophenolate mofetil (a medicine used to prevent the rejection of transplanted organs) works.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking this medicine.</p><p><strong>Important information about some of the ingredients of </strong><strong>Julmentin </strong></p><p>&middot;&nbsp; <strong>Julmentin </strong>contains sodium. This should be considered if you are on a controlled sodium diet.</p><p>&middot;&nbsp; <strong>Julmentin </strong>contains of potassium. This should be considered by patients with kidney problems or patients on a controlled potassium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will never give yourself this medicine. A qualified person, like a doctor or a nurse, will give you this medicine.</p><p>The recommended doses are:</p><p><strong>Adults, and children weighing 40 kg and over</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Standard dose</p></td><td style="vertical-align:top"><p>1,000 mg/200 mg every 8 hours.</p></td></tr><tr><td style="vertical-align:top"><p>To stop infections during and after surgery</p></td><td style="vertical-align:top"><p>1,000 mg/200 mg before the surgery when you are given your anaesthetic. The dose can differ depending on the type of operation you are having. Your doctor may repeat the dose if your surgery takes longer than 1 hour.</p></td></tr></tbody></table><p><strong>Children weighing less than 40 kg</strong></p><p>&nbsp;All doses are worked out depending on the child&rsquo;s bodyweight in kilograms.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Children aged 3 months and over:</p></td><td style="vertical-align:top"><p>25 mg/5 mg for each kilogram of bodyweight every 8 hours.</p></td></tr><tr><td style="vertical-align:top"><p>Children aged less than 3 months or weighing less than 4 kg</p></td><td style="vertical-align:top"><p>25 mg/5 mg for each kilogram of bodyweight every 12 hours.</p></td></tr></tbody></table><p><strong>Patients with kidney and liver problems</strong></p><p>&middot;&nbsp; If you have kidney problems you may be given a different dose. A different strength or a different medicine may be chosen by your doctor.</p><p>&middot;&nbsp; &nbsp;If you have liver problems your doctor will keep a close check on you and you may have more regular liver function tests.</p><p><strong>How Julmentin will be given to you</strong></p><p>&middot;&nbsp; <strong>Julmentin </strong>will be given as an injection into a vein or by intravenous infusion.</p><p>&middot;&nbsp; Make sure you drink plenty of fluids while having <strong>Julmentin</strong>.</p><p>&middot;&nbsp; You will not normally be given <strong>Julmentin </strong>for longer than 2 weeks without the doctor reviewing your treatment.</p><p><strong>If more Julmentin is given to you than recommended</strong></p><p>It is unlikely you will be given too much, but if you think you have been given too much <strong>Julmentin</strong>, tell your doctor, pharmacist or nurse immediately. Signs may be an upset stomach (feeling sick, being sick or diarrhoea) or convulsions.</p><p><strong>If you have any further questions about how this medicine is given, ask your doctor, pharmacist or nurse. </strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects below may happen with this medicine.</p><p><strong>Conditions you need to look out for</strong></p><p><strong>Allergic reactions:</strong></p><p>&middot;&nbsp; skin rash</p><p>&middot;&nbsp; inflammation of blood vessels (vasculitis) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&middot;&nbsp; fever, joint pain, swollen glands in the neck, armpit or groin</p><p>&middot;&nbsp; swelling, sometimes of the face or mouth (angioedema), causing difficulty in breathing</p><p>&middot;&nbsp; collapse.</p><p><strong>Contact a doctor immediately</strong> if you get any of these symptoms. <strong>Stop taking Julmentin.</strong></p><p><strong>Inflammation of large intestine</strong></p><p>Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever.</p><p><strong>Contact your doctor as soon as possible</strong> for advice if you get these symptoms.</p><p><strong>Common side effects</strong></p><p>These may affect up to 1 in 10 people</p><p>&middot;&nbsp; &nbsp;thrush (candida - a yeast infection of the vagina, mouth or skin folds)</p><p>&middot;&nbsp; &nbsp;diarrhoea</p><p><strong>Uncommon side effects</strong></p><p>These may affect up to 1 in 100 people</p><p>&middot;&nbsp; skin rash, itching</p><p>&middot;&nbsp; &nbsp;raised itchy rash (hives)</p><p>&middot;&nbsp; feeling sick (nausea), especially when taking high doses</p><p>&middot;&nbsp; &nbsp;vomiting</p><p>&middot;&nbsp; indigestion</p><p>&middot;&nbsp; dizziness</p><p>&middot;&nbsp; &nbsp;headache.</p><p><u>Uncommon side effects that may show up in your blood tests:</u></p><p>&middot;&nbsp; increase in some substances (enzymes) produced by the liver.</p><p><strong>Rare side effects</strong></p><p>These may affect up to 1 in 1,000 people</p><p>&middot;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge - erythema multiforme). If you notice any of these symptoms contact a doctor urgently.</p><p>&middot;&nbsp; &nbsp;swelling and redness along a vein which is extremely tender when touched</p><p><u>Rare side effects that may show up in your blood tests:</u></p><p>&middot;&nbsp; &nbsp;low number of cells involved in blood clotting</p><p>&middot;&nbsp; &nbsp;low number of white blood cells.</p><p><strong>Other side effects</strong></p><p>Other side effects have occurred in a very small number of people but their exact frequency is unknown.</p><p>&middot;&nbsp; Allergic reactions (see above)</p><p>&middot;&nbsp; Inflammation of the large intestine (see above)</p><p>&middot;&nbsp; Inflammation of the protective membrane surrounding the brain (aseptic meningitis)</p><p>&middot;&nbsp; Serious skin reactions:</p><p>-&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form, causing extensive peeling of the skin (more tha 30% of the body surface - toxic epidermal necrolysis)</p><p>-&nbsp; widespread red skin rash with small pus-containing blisters (bullous exfoliative dermatitis)</p><p>-&nbsp; a red, scaly rash with bumps under the skin and blisters (exanthemous pustulosis)</p><p>Contact a doctor immediately if you get any of these symptoms.</p><p>&middot;&nbsp; inflammation of the liver (hepatitis)</p><p>&middot;&nbsp; jaundice, caused by increases in the blood of bilirubin (a substance produced in the liver) which may make your skin and whites of the eyes appear yellow</p><p>&middot;&nbsp; &nbsp;inflammation of tubes in the kidney</p><p>&middot;&nbsp; blood takes longer to clot</p><p>&middot;&nbsp; convulsions (in people taking high doses of <strong>Julmentin </strong>&nbsp;or who have kidney problems).</p><p><u>Side effects that may show up in your blood or urine tests:</u></p><p>&middot;&nbsp; severe reduction in the number of white blood cells</p><p>&middot;&nbsp; low number of red blood cells (haemolytic anaemia)</p><p>&middot;&nbsp; crystals in urine.</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or nurse.</strong></p><p><strong>&nbsp;</strong></p><p><strong><u>To report any side effect(s)</u></strong><strong><u>: </u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222,</p><p><strong>Exts: </strong>2317-2356-2353-2354-2334-2340<strong>.</strong></p><p><strong>Toll free phone: </strong>8002490000</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not use <strong>Julmentin</strong> after the expiry date which is stated on the carton and the inner label.</p><p>-&nbsp; Before reconstitution, Do not store above 25&deg;C, protect from light and heat.&nbsp;</p><p>-&nbsp; After reconstitution, use immediately. Do not freeze.</p><p>-&nbsp; Do not use <strong>Julmentin</strong> if you notice any visible sign of deterioration.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><u>Julmentin 0.6gm injection: </u></strong></p><p>Each vial contains 500mg amoxicillin as amoxicillin sodium and 100mg clavulanic acid as potassium clavulanate.</p><p><strong><u>Julmentin 1.2gm injection: </u></strong></p><p>Each vial contains 1g amoxicillin as amoxicillin sodium and 200mg clavulanic acid as potassium clavulanate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Julmentin 0.6g and 1.2g Injection are available in pack of 1 or 10 vials.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>Manufactured by:&nbsp; </strong>Sandoz GmBH - Austria</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For:&nbsp;&nbsp;&nbsp;</strong>Gulf Pharmaceutical Industries (<strong>Julphar</strong>),<br />Ras Al Khaimah, U.A.E.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/02/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>جلمنتين </strong>هو مضاد حيوي يعمل عن طريق القضاء على البكتيريا المسببة في حدوث العدوى. ويحتوي على نوعين مختلفين من الدواء هما أموكسيسيلين وحمض كلافيولانيك.</p><p dir="RTL">ينتمي أموكسيسيلين إلى مجموعة من الأدوية التي تعرف باسم &quot;البنسلينات&quot; ,والذي يمكن في بعض الأحيان أن يتوقف عن العمل (يصبح غير نشط). بينما تعمل المادة الأخرى في هذا الدواء (حمض كلافيولانيك) على منع حدوث ذلك الأمر.</p><p dir="RTL"><strong>يستخدم جلمنتين من قبل البالغين والأطفال لعلاج حالات العدوى التالية:</strong></p><p dir="RTL">&middot; عدوى الأذن، الأنف والحلق الشديدة</p><p dir="RTL">&middot; عدوى الجهاز التنفسي</p><p dir="RTL">&middot; عدوى المسالك البولية</p><p dir="RTL">&middot; عدوى الجلد والأنسجة الرخوة بما في ذلك عدوى الأسنان</p><p dir="RTL">&middot; عدوى العظام والمفاصل</p><p dir="RTL">&middot; عدوى داخل البطن</p><p dir="RTL">&middot; عدوى الأعضاء التناسلية لدى النساء</p><p dir="RTL">كما يستخدم <strong>جلمنتين </strong>من قبل البالغين والأطفال لمنع حدوث العدوى الناجمة عن العمليات الجراحية الكبرى.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم إعطاء جلمنتين في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp; إذا كنت تعاني من الحساسية تجاه أموكسيسيلين، حمض الكلافيولانيك، البنسلين أو أياً من المكونات الأخرى في هذا الدواء<strong> </strong>(المذكورة في قسم 6)</p><p dir="RTL">&middot;&nbsp; إذا عانيت مسبقاً من تفاعل تحسسي شديد (فرط الحساسية) تجاه أياً من المضادات الحيوية الأخرى. وقد يتضمن ذلك حدوث طفح جلدي أو تورم في الوجه أو الرقبة</p><p dir="RTL">&middot;&nbsp; إذا عانيت مسبقاً من مشاكل في الكبد أو يرقان (اصفرار الجلد) عند تناول أياً من المضادات الحيوية.</p><p dir="RTL"><strong>يجب عدم إعطائك جلمنتين إذا كان أي من المذكور أعلاه ينطبق عليك. &nbsp;</strong>إذا لم تكن متأكداً من ذلك، يرجى منك إخبار طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض قبل إعطائك<strong> جلمنتين</strong>.</p><p dir="RTL"><strong>عناية خاصة مع استعمال </strong><strong>جلمنتين</strong></p><p dir="RTL">يرجى منك التحدث مع طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض &nbsp;قبل ان يتم إعطائك <strong>جلمنتين </strong>إذا كنت:</p><p dir="RTL">&middot;&nbsp; &nbsp;تعاني الحمى الغدية</p><p dir="RTL">&middot;&nbsp; &nbsp;تتلقى علاجاً لمشاكل في الكبد أو الكلى.</p><p dir="RTL">&middot;&nbsp; &nbsp;تعاني من عدم انتظام التبول.</p><p dir="RTL">في حال مالم تكن متأكداً ما إذا كان أياً من المذكور أعلاه ينطبق عليك، يرجى منك التحدث إلى طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض قبل إعطائك<strong> جلمنتين</strong>.</p><p dir="RTL">في بعض الحالات، قد يحتاج طبيبك المعالج بإجراء فحصاً مختبري لمعرفة نوع البكتيريا المسببة للعدوى لك. وبناءً على نتائج هذا الفحص، قد يعطى لك <strong>جلمنتين</strong> بتركيز مختلف أو قد يعطى لك دواء آخر.</p><p dir="RTL"><strong>الحالات التي تتطلب منك الانتباه</strong></p><p dir="RTL">قد يسبب <strong>جلمنتين </strong>تفاقم بعض الحالات المرضية التي تعاني منها، أو قد يسبب حدوث تأثيرات جانبية خطيرة. بما في ذلك التفاعلات التحسسية، تشنجات (اختلاجات) والتهاب في الأمعاء الغليظة. يجب عليك الانتباه من حدوث أعراض معينة التي قد تحدث أثناء فترة استعمال <strong>جلمنتين</strong>، وذلك لتقليل من خطر حدوث أية مشاكل. انظر &quot;الحالات التي تتطلب منك الانتباه&quot; المذكورة في <strong>قسم 4</strong>.</p><p dir="RTL"><strong>فحوصات الدم والبول</strong></p><p dir="RTL">إذا كنت ستخضع لفحوصات الدم (على سبيل المثال فحوصات خلايا الدم الحمراء أو فحوصات وظائف الكبد) أو فحوصات البول (لفحص البول السكري)، فإنه يجب عليك إخبار الطبيب المعالج أو الممرض بأنه يتم إعطائك <strong>جلمنتين</strong><strong>.</strong> وذلك لأن <strong>جلمنتين </strong>يمكن أن يؤثر على نتائج هذه الفحوصات.</p><p dir="RTL"><strong>تناول الأدوية الأخرى مع </strong><strong>جلمنتين</strong><strong>:</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج ، الصيدلي الذي تتعامل معه أو الممرض إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى. بما في ذلك الأدوية التي تصرف بدون وصفة طبية والأدوية العشبية.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول ألوبيورينول (دواء يستخدم لعلاج النقرس) بالتزامن مع <strong>جلمنتين</strong>، فإنه من المرجح حدوث تفاعل جلدي تحسسي.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول بروبنسيد (دواء يستخدم لعلاج النقرس) بالتزامن مع <strong>جلمنتين</strong>، فقد يقرر طبيبك المعالج بتعديل جرعة<strong> جلمنتين</strong> الخاصة بك.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول الأدوية التي تمنع تخثر الدم على سبيل المثال (الوارفارين) بالتزامن مع <strong>جلمنتين</strong> فسوف يتطلب إجراء فحوصات دموية إضافية.</p><p dir="RTL">&middot; قد يؤثر<strong> جلمنتين </strong>على آلية عمل ميثوتركسات (دواء يستخدم لعلاج السرطان أو الأمراض الروماتيزمية).</p><p dir="RTL">&middot; كما قد يؤثر<strong> جلمنتين </strong>على آلية عمل مايكوفينولات موفيتل (دواء يستخدم لمنع رفض الجسم الأعضاء المزروعة).</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج، الصيدلي الذي تتعاملين معه أو الممرض للحصول على المشورة قبل إعطائك هذا الدواء، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين بأنك حاملاً، أو تخططين لإنجاب طفلاً.</p><p dir="RTL"><strong>معلومات هامة عن بعض مكونات</strong> <strong>جلمنتين</strong></p><p dir="RTL">&middot;&nbsp; يحتوي <strong>جلمنتين</strong> على الصوديوم. يجب أخذ ذلك بعين الاعتبار إذا كنت تتبع نظاماً غذائياً متوازن في مستوى الصوديوم</p><p dir="RTL">&middot;&nbsp; يحتوي <strong>جلمنتين</strong> على البوتاسيوم. يجب ذلك بعين الاعتبار من قبل المرضى الذين يعانون من مشاكل في الكلى أو المرضى الذيت يتبعون نظاماً غذائياُ متوازن في مستوى البوتاسوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;يجب عدم أخذ هذا الدواء من تلقاء نفسك على الإطلاق. سوف يتم إعطائك هذا الدواء من قبل شخص مؤهل لذلك، على سبيل المثال الطبيب المعالج أو الممرض.</p><p dir="RTL"><strong>الجرعات الموصى بها هي:</strong></p><p dir="RTL"><strong>البالغين والأطفال الذين تبلغ أوزانهم 40 كيلوغرام&nbsp; فما فوق</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">الجرعة الاعتيادية</p></td><td style="vertical-align:top"><p dir="RTL">1000ملغم/200ملغم كل 8 ساعات</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">لمنع حدوث العدوى أثناء و بعد إجراء العملية الجراحية</p></td><td style="vertical-align:top"><p dir="RTL">1000ملغم/200ملغم قبل إجراء العملية الجراحية عند إعطاء المخدر. من الممكن أن تختلف الجرعة وذلك اعتمادا على نوع العملية الجراحية.</p><p dir="RTL">قد يكرر طبيبك المعالج الجرعة إذا كانت العملية الجراحية تستغرق أكثر من ساعة واحدة.</p></td></tr></tbody></table><p dir="RTL"><strong>الأطفال الذين تبلغ أوزانهم أقل من 40 كيلوغرام </strong></p><p dir="RTL">يتم اختيار كل جرعة اعتماداً على وزن جسم الطفل بالكيلوغرام</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">الأطفال بعمر 3 شهور فما فوق</p></td><td style="vertical-align:top"><p dir="RTL">25ملغم/5ملغم لكل كيلوغرام من وزن الجسم كل 8 ساعات</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">الأطفال بعمر أقل من 3 شهور أو الذين تبلغ أوزانهم أقل من&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;4 كيلوغرام</p></td><td style="vertical-align:top"><p dir="RTL">25ملغم/5ملغم لكل كيلوغرام من وزن الجسم كل 12 ساعة</p></td></tr></tbody></table><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكلى والكبد</strong></p><p dir="RTL">&middot; إذا كنت تعاني من مشاكل في الكلى فقد يتم إعطائك جرعة مختلفة. &nbsp;وقد يقوم طبيبك المعالج باختيار تركيزاً مختلفاً أو دواءً مختلفاً.</p><p dir="RTL">&middot; إذا كنت تعاني من مشاكل في الكبد فسوف يقوم طبيبك المعالج بإجراء فحوصات عن كثب وقد تحتاج لإجراء فحوصات وظيفة الكبد بشكل دوري أكثر.</p><p dir="RTL"><strong>كيفية إعطاء جلمنتين</strong></p><p dir="RTL"><strong>&middot; </strong>سوف يتم إعطاء <strong>جلمنتين </strong>عن طريق الحقن في الوريد أو التسريب الوريدي.</p><p dir="RTL"><strong>&middot; </strong>احرص على شرب كمية كافية من الماء عند إعطائك <strong>جلمنتين</strong>.</p><p dir="RTL"><strong>&middot; </strong>أنه ليس من الطبيعي إعطائك <strong>جلمنتين </strong>لأكثر من أسبوعين من دون مراجعة العلاج الخاص بك من قبل الطبيب المعالج.</p><p dir="RTL"><strong>إذا تم إعطائك </strong><strong>جلمنتين </strong><strong>بجرعة أكبر مما يجب</strong></p><p dir="RTL">ليس من المحتمل أن يتم إعطائك<strong> جلمنتين </strong>بجرعة أكبر مما يجب، ولكن إذا كنت تعتقد&nbsp; بإنه تم إعطائك <strong>جلمنتين </strong>بجرعة أكبر مما يجب، فيرجى منك إخبار طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض على الفور. قد تتضمن علامات الجرعة الزائدة على اضطراب في المعدة (شعور بالإعياء، وتوعك أو إسهال) أو تشنجات.</p><p dir="RTL"><strong>يرجى منك استشارة الطبيب المعالج، الصيدلي الذي تتعامل معه أو الممرض، إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء إلى حدوث تأثيرات جانبية، ولكنها قد لا تحدث لكل شخص. قد تحدث التأثيرات الجانبية المذكورة أدناه أثناء فترة استعمال هذا الدواء.</p><p dir="RTL"><strong>الحالات التي تتطلب منك الإنتباه </strong></p><p dir="RTL"><strong>حدوث تفاعلات تحسسية:</strong></p><p dir="RTL">&middot;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp; التهاب الأوعية الدموية الذي يظهر على شكل بقع حمراء أو بنفسجية مرتفعة عن سطح الجلد، ولكن قد يؤثر على الأجزاء الأخرى من الجسم</p><p dir="RTL">&middot;&nbsp; حمى، ألم في المفاصل، تورم الغدد في منطقة الرقبة، الفخذين أو الإبطين</p><p dir="RTL">&middot;&nbsp; تورم، والذي يشمل في بعض الأحيان الوجه أو الفم (وذمة وعائية)، مسببة صعوبة في التنفس</p><p dir="RTL">&middot;&nbsp; تدهورعام في الصحة.</p><p dir="RTL"><strong>يرجى التواصل مع الطبيب المعالج&nbsp; على </strong><strong>الفور</strong> إذا تعرضت لأي من هذه الأعراض.<strong> وتوقف عليك التوقف عن أخذ جلمنتين</strong>.</p><p dir="RTL"><strong>التهاب الأمعاء الغليظة</strong></p><p dir="RTL">قد يؤدي التهاب الأمعاء الغليظة إلى حدوث إسهال مائي مصحوب عادةً بالدم والمخاط، ألم في المعدة و/أو حمى.</p><p dir="RTL"><strong>يرجى منك التواصل مع طبيبك المعالج في أقرب وقت ممكن</strong> للحصول على المشورة في حال تعرضك لأي من هذه الأعراض. &nbsp;</p><p dir="RTL"><strong>التأثيرات الجانبية الشائعة</strong></p><p dir="RTL">قد توثر على ما يصل إلى شخص واحد من كل 10 أشخاص&nbsp;</p><p dir="RTL">&middot;&nbsp; مرض القلاع (الكانديدا &ndash; عدوى الخميرة في المهبل، الفم أو الثنايا الجلدية)</p><p dir="RTL">&middot;&nbsp; إسهال</p><p dir="RTL"><strong>التأثيرات الجانبية الغير شائعة</strong></p><p dir="RTL">قد توثر على ما يصل إلى شخص واحد من كل 100 شخص&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp; </strong>طفح جلدي، حكة</p><p dir="RTL">&middot;&nbsp; طفح مصحوب بحكة (طفح جلدي شبيهه بخلايا النحل)</p><p dir="RTL">&middot;&nbsp; الشعور بالإعياء (غثيان)،&nbsp; وبصفة خاصة يحدث ذلك عند استعمال عند تناول جرعات عالية</p><p dir="RTL">&middot;&nbsp; تقيؤ</p><p dir="RTL">&middot;&nbsp; عسر هضم</p><p dir="RTL">&middot;&nbsp; دوخة</p><p dir="RTL">&middot;&nbsp; صداع</p><p dir="RTL"><u>التأثيرات الجان</u><u>ب</u><u>ية الغير شائعة التي قد تظهر عند إجراء فحوصات&nbsp; الدم:</u></p><p dir="RTL"><strong>&middot;&nbsp; </strong>زيادة في إفراز بعض المواد (الإنزيمات) التي يتم إنتاجها بواسطة الكبد.</p><p dir="RTL"><strong>التأثيرات الجانبية النادرة</strong></p><p dir="RTL">قد توثر على ما يصل إلى شخص واحد من كل 1000 شخص</p><p dir="RTL">&middot;&nbsp; طفح جلدي، الذي قد يكون&nbsp; بصورة تقرحات ، ويبدو على هيئة أقراص دائرية صغيرة (بقع داكنة في المركز محاطة بمنطقة شاحبة اللون مع وجود حلقة داكنة حول الأطراف &ndash; حمامي متعددة الأشكال) إذا لاحظت أياً من هذه الأعراض، يرجى منك التواصل مع الطبيب المعالج على الفور.</p><p dir="RTL">&middot;&nbsp; تورم واحمرار الأوردة والشعور بألم شديد عن ضغط عليها.</p><p dir="RTL"><u>التأثيرات الجانبية نادرة التي قد تظهر عند إجراء فحوصات الدم:</u></p><p dir="RTL">&middot;&nbsp; نقص عدد الخلايا المساهمة في عملية تجلط الدم</p><p dir="RTL">&middot;&nbsp; نقص عدد خلايا الدم البيضاء.</p><p dir="RTL"><strong>التأثيرات الجانبية الأخرى</strong></p><p dir="RTL">لقد حدثت تأثيرات جانبية أخرى لدى عدد قليل جداً من الأشخاص ولكن لم يعرف معدل تكرار حدوثها.</p><p dir="RTL">&middot;&nbsp; تفاعلات تحسسية (انظر أعلاه)</p><p dir="RTL">&middot;&nbsp; التهاب الأمعاء الغليظة (انظر أعلاه)</p><p dir="RTL">&middot;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ (التهاب السحايا العقيم)</p><p dir="RTL">&middot;&nbsp; تفاعلات جلدية خطيرة:</p><p dir="RTL">-&nbsp; طفح جلدي منتشر على مساحة واسة من الجلد مصحوباً بظهور تقرحات وتقشر الجلد، , وبصفة خاصةَ حول الفم، الأنف، العينين والأعضاء التناسلية (متلازمة ستيفنز-جونسون)، وقد يؤدي النوع الأكثر خطورة من هذا المرض إلى حدوث تقشر في مساحات واسعة من الجلد (أكثر من 30٪ من سطح الجسم- انحلال البشرة السمي التنخري).&nbsp;&nbsp;&nbsp;</p><p dir="RTL">-&nbsp; طفح جلدي منتشر على مساحة واسة من الجلد أحمراللون مصحوباً بظهور بثور صغيرة متقيحة (التهاب الجلد التقشري الفقاعي)</p><p dir="RTL">-&nbsp; &nbsp;طفح جلدي أحمر اللون متقشر مصحوباً بظهور نتوءات تحت الجلد وتقرحات (الطفح البثري).</p><p dir="RTL">يرجى منك التواصل مع الطبيب المعالج على الفور إذا تعرضت لأياً من هذه الأعراض.</p><p dir="RTL">&middot;&nbsp; التهاب الكبد</p><p dir="RTL">&middot;&nbsp; يرقان، الناجم عن زيادة البليروبين في الدم (مادة التي تفرز عن طريق الكبد) والذي قد يؤدي إلى اصفرار لون الجلد وبياض العينين</p><p dir="RTL">&middot;&nbsp; التهاب الأنابيب في الكلى</p><p dir="RTL">&middot;&nbsp; زيادة الفترة الزمنية اللازمة لتخثر الدم</p><p dir="RTL">&middot;&nbsp; تشنجات (تحدث لدى المرضى الذين يستعملون جرعات عالية من <strong>جلمنتين</strong> أو الذين يعانون من مشاكل في الكلى)</p><p dir="RTL"><u>التأثيرات الجانبية التي قد تظهر عند إجراء فحوصات الدم أو البول:</u></p><p dir="RTL">&middot;&nbsp; نقص شديد في تعداد خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp; نقص عدد خلايا الدم الحمراء (فقر الدم الإنحلالي)</p><p dir="RTL">&middot;&nbsp; ظهور بلورات في البول</p><p dir="RTL"><strong>يرجى منك استشارة الطبيب المعالج، الصيدلي الذي تتعامل معه أو الممرض، إذا زادت حدة أي من هذه التأثيرات الجانبية، أو بما في ذلك الأعراض الجانبية والتي لم تذكر في هذه النشرة. </strong></p><p dir="RTL"><strong><u>&nbsp;</u></strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp; يجب عدم استعمال <strong>جلمنتين </strong>بعد تاريخ انتهاء الصلاحية المذكورعلى العبوة والملصق الداخلي.</p><p dir="RTL">-&nbsp; قبل التحضير، يحفظ في درجة حرارة لا تتعدى &ordm;25م، بعيداً عن الضوء والحرارة.</p><p dir="RTL">-&nbsp; بعد التحضير، استخدم المحلول المحضر مباشرة. تجنب تجميده.</p><p dir="RTL">-&nbsp; يجب عدم استعمال <strong>جلمنتين </strong>إذا لاحظت وجود &nbsp;أي علامات تلف واضحة.</p><p dir="RTL">-&nbsp; &nbsp;يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن &nbsp;&nbsp;كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>حقن جلمنتين 0,6غرام</u></strong></p><p dir="RTL">تحتوي كل زجاجة على أموكسيسيلين الصوديوم بما يعادل 500 ملغم أموكسيسيلين وكلافيولانيت البوتاسيوم بما يعادل 100 ملغم حمض الكلافيولانيك.</p><p dir="RTL"><strong><u>حقن جلمنتين 1,2غرام</u></strong></p><p>تحتوي كل زجاجة على أموكسيسيلين الصوديوم بما يعادل 1 غرام أموكسيسيلين وكلافيولانيت البوتاسيوم بما يعادل 200 ملغم حمض الكلافيولانيك</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>تتوفر<strong> حقن جلمنتين 0,6 غرام و1,2 غرام</strong> في عبوة تحتوي على 1 أو 10 زجاجات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المصنّع</strong>:&nbsp; ساندوز - النمسا&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>لصالح: </strong>&nbsp;الخليج للصناعات الدوائية (<strong>جلفار</strong>)، رأس الخيمة،</p><p><br />الإمارات العربية المتحدة.<strong> </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01-02-2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Julmentin 0.6gm Powder for Solution for I.V. Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains:
Item No.	Material Name	Scale (mg/Vial)
		
	Active Ingredients:	
1.		Amoxicillin 	500.00
	As Sterile  Amoxicillin Sodium	612.75
2.		Clavulanic Acid	100.00
	As Sterile Potassium Clavulanate	134.50

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for Solution for I.V. Injection
Description: White to off-white powder.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Julmentin</strong> is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):</p><p>&sect; Severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms)</p><p>&sect; Acute exacerbations of chronic bronchitis (adequately diagnosed)</p><p>&sect; Community acquired pneumonia</p><p>&sect; Cystitis</p><p>&sect; Pyelonephritis</p><p>&sect; Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis</p><p>&sect; Bone and joint infections, in particular osteomyelitis</p><p>&sect; Intra-abdominal infections</p><p>&sect; Female genital infections.</p><p>Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the:</p><p>&sect; Gastrointestinal tract</p><p>&sect; Pelvic cavity</p><p>&sect; Head and neck</p><p>&sect; Biliary tract surgery.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p>Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.</p><p>&nbsp;</p><p>The dose of <strong>Julmentin </strong>that is selected to treat an individual infection should take into account:</p><p>&sect; The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)</p><p>&sect; The severity and the site of the infection</p><p>&sect; The age, weight and renal function of the patient as shown below.</p><p>The use of alternative presentations of <strong>Julmentin</strong> (e.g. those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1).&nbsp;</p><p>This <strong>Julmentin</strong> powder for solution for injection or infusion provides a total daily dose of 3000mg amoxicillin and 600mg clavulanic acid when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required it is recommended that an alternative intravenous formulation of amoxicillin/clavulanic acid is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid.</p><p>The duration of therapy should be determined by the response of the patient. Some infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy).</p><p>Consideration should be given to local guidelines on appropriate dosing frequencies for amoxicillin/clavulanic acid.</p><p><strong><u>Adults and children &ge; 40 kg</u></strong></p><p>For treatment of infections as indicated in section 4.1: 1000 mg/ 200 mg every 8 hours</p><table border="1" cellspacing="0" cellpadding="0" style="width:554px"><tbody><tr><td style="vertical-align:top"><p>For surgical prophylaxis</p></td><td style="vertical-align:top"><p>For procedures less than 1 hour in duration, the recommended dose of amoxicillin/clavulanic acid is 1000mg/200mg to 2000mg/200mg given at induction of anaesthesia (Doses of 2000mg/200mg can be achieved by using an alternative intravenous formulation of amoxicillin/clavulanic acid).&nbsp;&nbsp;</p><p>For procedures greater than 1 hour in duration, the recommended dose of amoxicillin/clavulanic acid is 1000mg/200mg to 2000mg/200mg given at induction of anaesthesia, with up to 3 doses of 1000mg/200mg in 24 hours.</p><p>Clear clinical signs of infection at operation will require a normal course of intravenous or oral therapy post-operatively.</p></td></tr></tbody></table><p><strong><u>Children &lt; 40 kg</u></strong></p><p>Recommended doses:</p><p>&sect; <em>Children aged 3 months and over:</em>&nbsp;25 mg/5 mg per kg every 8 hours</p><p>&sect; <em>Children aged less than 3 months or weighing less than 4 kg:</em>&nbsp;25 mg/5 mg per kg every 12 hours.</p><p><strong><u>Elderly</u></strong></p><p>No dose adjustment is considered necessary.</p><p><strong><u>Renal impairment</u></strong></p><p>Dose adjustments are based on the maximum recommended level of amoxicillin.</p><p>No dose adjustment is required in patients with creatinine clearance (CrCl) greater than 30 ml/min.</p><p><strong><em><u>Adults and children &ge; 40 kg</u></em></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:554px"><tbody><tr><td style="vertical-align:top"><p>CrCl: 10-30 ml/min</p></td><td style="vertical-align:top"><p>Initial dose of 1000mg/200mg and then 500mg/100mg given twice daily</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 ml /min</p></td><td style="vertical-align:top"><p>Initial dose of 1000mg/200mg and then 500mg/100mg given every 24 hours</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>Initial dose of 1000mg/200mg and then followed by 500mg/100mg every 24 hours, plus a dose of 500mg/100mg at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)</p></td></tr></tbody></table><p><strong><em><u>Children &lt; 40 kg</u></em></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:554px"><tbody><tr><td style="vertical-align:top"><p>CrCl: 10 to 30 ml/min</p></td><td style="vertical-align:top"><p>25mg/5mg per kg given every 12 hours</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 ml /min</p></td><td style="vertical-align:top"><p>25mg/5mg per kg given every 24 hours</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>25mg/5mg per kg given every 24 hours, plus a dose of 12.5mg/2.5mg per kg at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased).</p></td></tr></tbody></table><p><strong><u>Hepatic impairment</u></strong></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4).</p><p><strong><u>Method of administration</u></strong></p><p><strong>Julmentin</strong> is for intravenous use.</p><p><strong>Julmentin</strong> may be administered either by slow intravenous injection over a period of 3 to 4 min directly into a vein or via a drip tube or by infusion over 30 to 40 min. <strong>Julmentin</strong> is not suitable for intramuscular administration.&nbsp;</p><p>Children aged less than 3 months should be administered <strong>Julmentin</strong> by infusion only.</p><p>Treatment with <strong>Julmentin</strong> may be initiated by the use of an intravenous preparation and completed with an appropriate oral presentation as considered appropriate for the individual patient.&nbsp;</p><p>For instructions on reconstitution and dilution of the medicinal product before administration, see section 6.6.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients listed in section 6.1.
	History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
	History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other beta-lactam agents (see sections 4.3 and 4.8).</p><p>Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin/clavulanic acid therapy must be discontinued and appropriate alternative therapy instituted.</p><p>In the case that an infection is proven to be due to an amoxicillin-susceptible organisms(s) then consideration should be given to switching from amoxicillin/clavulanic acid to amoxicillin in accordance with official guidance.</p><p>This presentation of amoxicillin/clavulanic acid may not be suitable for use when there is a high risk that the presumptive pathogens have resistance to beta-lactam agents that is not mediated by beta-lactamases susceptible to inhibition by clavulanic acid. As no specific data for T&gt;MIC are available and the data for comparable oral presentations are borderline, this presentation (without additional amoxicillin) may not be suitable for the treatment of penicillin-resistant&nbsp;<em>S. pneumoniae</em>.</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses (see section 4.8).</p><p>Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.</p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>The occurrence at the treatment initiation of a feverish generalised erythema associated with pustula may be a symptom of acute generalised exanthemous pustulosis (AGEP) (see section 4.8). This reaction requires amoxicillin/clavulanic acid discontinuation and contraindicates any subsequent administration of amoxicillin.</p><p>Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic impairment (see sections 4.2, 4.3 and 4.8).</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children. In all populations, signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased. These are usually reversible. Hepatic events may be severe, and in extremely rare circumstances, deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects (see section 4.8).</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents including amoxicillin and may range in severity from mild to life threatening (see section 4.8). Therefore, it is important to consider this diagnosis in patients who present with diarrhoea during or subsequent to the administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a physician be consulted and an appropriate therapy initiated. Anti-peristaltic medicinal products are contraindicated in this situation.</p><p>Periodic assessment of organ system functions; including renal, hepatic and haematopoietic function is advisable during prolonged therapy.</p><p>Prolongation of prothrombin time has been reported rarely in patients receiving amoxicillin/clavulanic acid. Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation (see sections 4.5 and 4.8).</p><p>In patients with renal impairment, the dose should be adjusted according to the degree of impairment (see section 4.2).</p><p>In patients with reduced urine output crystalluria has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see section 4.9).</p><p>During treatment with amoxicillin, enzymatic glucose oxidase methods should be used whenever testing for the presence of glucose in urine because false positive results may occur with non-enzymatic methods.</p><p>The presence of clavulanic acid in amoxicillin/clavulanic acid injection may cause a non-specific binding of IgG and albumin by red cell membranes leading to a false positive Coombs test.</p><p>There have been reports of positive test results using the Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test in patients receiving amoxicillin/clavulanic acid who were subsequently found to be free of&nbsp;<em>Aspergillus</em>&nbsp;infection. Cross-reactions with non-<em>Aspergillus</em>polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia&nbsp;<em>Aspergillus</em>&nbsp;EIA test have been reported. Therefore, positive test results in patients receiving amoxicillin/clavulanic acid should be interpreted cautiously and confirmed by other diagnostic methods.</p><p>&nbsp;</p><p><strong><u>Julmentin powder for solution for injection or infusion contains:</u></strong></p><p>&sect; Sodium. To be taken into consideration by patients on a controlled sodium diet.</p><p>&sect; Potassium. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Oral anticoagulants</u></strong></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction. However, in the literature there are cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see sections 4.4 and 4.8).</p><p><strong><u>Methotrexate</u></strong></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p><p><strong><u>Probenecid</u></strong></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p><strong><u>Mycophenolate mofetil</u></strong></p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid (MPA) of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure. Therefore, a change in the dose of mycophenolate mofetil should not normally be necessary in the absence of clinical evidence of graft dysfunction. However, close clinical monitoring should be performed during the combination and shortly after antibiotic treatment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3). Limited data on the use of amoxicillin/clavulanic acid during pregnancy in humans do not indicate an increased risk of congenital malformations. In a single study in women with preterm, premature rupture of the foetal membrane it was reported that prophylactic treatment with amoxicillin/clavulanic acid may be associated with an increased risk of necrotising enterocolitis in neonates. Use should be avoided during pregnancy, unless considered essential by the physician.</p><p><strong><u>Breastfeeding</u></strong></p><p>Both substances are excreted into breast milk (nothing is known of the effects of clavulanic acid on the breast-fed infant). Consequently, diarrhoea and fungus infection of the mucous membranes are possible in the breast-fed infant, so that breast-feeding might have to be discontinued. The possibility of sensitisation should be taken into account. Amoxicillin/clavulanic acid should only be used during breast-feeding after benefit/risk assessment by the physician in charge.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions), which may influence the ability to drive and use machines (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and vomiting.</p><p>The ADRs derived from clinical studies and post-marketing surveillance with Amoxicillin/clavulanic acid, sorted by MedDRA System Organ Class are listed below.</p><p>The following terminologies have been used in order to classify the occurrence of undesirable effects.</p><p>&sect; Very common (&ge;1/10)</p><p>&sect; Common (&ge;1/100 to &lt;1/10)</p><p>&sect; Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>&sect; Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>&sect; Very rare (&lt;1/10,000)</p><p>&sect; Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:542px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><u>Infections and infestations</u></p></td></tr><tr><td style="vertical-align:top"><p>Mucocutaneous candidosis</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Overgrowth of non-susceptible organisms</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Blood and lymphatic system disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Reversible leucopenia (including neutropenia)</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Reversible agranulocytosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Haemolytic anaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Prolongation of bleeding time and prothrombin time<sup>1</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Immune system disorders</u><sup>10</sup></p></td></tr><tr><td style="vertical-align:top"><p>Angioneurotic oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylaxis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Serum sickness-like syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity vasculitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Nervous system disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Convulsions<sup>2</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Aseptic meningitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Vascular disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Thrombophlebitis<sup>3</sup></p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Gastrointestinal disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Indigestion</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Antibiotic-associated colitis<sup>4</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Hepatobiliary disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Rises in AST and/or ALT<sup>5</sup></p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cholestatic jaundice<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Skin and subcutaneous tissue disorders<sup>7</sup></u></p></td></tr><tr><td style="vertical-align:top"><p>Skin rash</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Erythema multiforme</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bullous exfoliative-dermatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Acute generalised exanthemous pustulosis (AGEP)<sup>9</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Renal and urinary disorders</u></p></td></tr><tr><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Crystalluria<sup>8</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>1</sup>&nbsp;See section 4.4</p><p><sup>2</sup>&nbsp;See section 4.4</p><p><sup>3</sup>&nbsp;At the site of injection</p><p><sup>4&nbsp;</sup>Including pseudomembranous colitis and haemorrhagic colitis (see section 4.4)</p><p><sup>5</sup>&nbsp;A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p><sup>6&nbsp;</sup>These events have been noted with other penicillins and cephalosporins (see section 4.4).</p><p><sup>7</sup>&nbsp;If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued (see section 4.4).</p><p><sup>8</sup>&nbsp;See section 4.9</p><p><sup>9</sup>&nbsp;See section 4.4</p><p><sup>10</sup>&nbsp;See sections 4.3 and 4.4</p></td></tr></tbody></table><p>&nbsp;</p><p><strong><u>To report any side effect(s):</u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs of overdose</u></strong></p><p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see section 4.4).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after intravenous administration of large doses. A regular check of patency should be maintained (see section 4.4).</p><p><strong><u>Treatment of intoxication</u></strong></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>Amoxicillin/clavulanic acid can be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group: </strong>Combinations of penicillins, incl. beta-lactamase inhibitors;</p><p><strong>ATC code: </strong>J01CR02.</p><p><strong><u>Mechansim of action</u></strong></p><p>Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria and therefore the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. Clavulanic acid alone does not exert a clinically useful antibacterial effect.</p><p><strong><u>Pharmacokinetic/pharmacodynamic relationship</u></strong></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be the major determinant of efficacy for amoxicillin.</p><p><strong><u>Mechanisms of resistance</u></strong></p><p>The two main mechanisms of resistance to amoxicillin/clavulanic acid are:</p><p>&sect; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by clavulanic acid, including class B, C and D.</p><p>&sect; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial resistance, particularly in Gram-negative bacteria.</p><p><strong><u>Breakpoints</u></strong></p><p>MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST)</p><table border="1" cellspacing="0" cellpadding="0" style="width:548px"><tbody><tr><td style="vertical-align:top"><p>Organism</p></td><td colspan="3" style="vertical-align:top"><p>Susceptibility Breakpoints (&mu;g/ml)</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Susceptible</p></td><td style="vertical-align:top"><p>Intermediate</p></td><td style="vertical-align:top"><p>Resistant</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 1</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em><strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Coagulase-negative staphylococci&nbsp;<strong><sup>2</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus</em><strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A, B, C, G</em><strong><sup>5</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em><strong><sup>3</sup></strong></p></td><td style="vertical-align:top"><p>&le; 0.5</p></td><td style="vertical-align:top"><p>1-2</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae<strong><sup>1,4</sup></strong></p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-negative Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-positive Anaerobes<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<strong><sup>1</sup></strong></p></td><td style="vertical-align:top"><p>&le; 2</p></td><td style="vertical-align:top"><p>4-8</p></td><td style="vertical-align:top"><p>&gt; 8</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><sup>1</sup>&nbsp;The reported values are for amoxicillin concentrations. For susceptibility testing purposes, the concentration of clavulanic acid is fixed at 2 mg/l.</p><p><sup>2</sup>&nbsp;The reported values are oxacillin concentrations.</p><p><sup>3</sup>&nbsp;Breakpoint values in the table are based on ampicillin breakpoints.</p><p><sup>4</sup>&nbsp;The resistant breakpoint of R&gt;8 mg/l ensures that all isolates with resistance mechanisms are reported resistant.</p><p><sup>5</sup>&nbsp;Breakpoint values in the table are based on benzylpenicillin breakpoints.</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species, and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:548px"><tbody><tr><td style="vertical-align:top"><p><u>Commonly susceptible species</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecalis</em></p><p><em>Gardnerella vaginalis</em></p><p><em>Staphylococcus aureus&nbsp;</em>(methicillin-susceptible)&pound;</p><p>Coagulase-negative staphylococci (methicillin-susceptible)</p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae</em><sup>1</sup></p><p><em>Streptococcus pyogenes</em>&nbsp;and other beta-haemolytic streptococci</p><p><em>Streptococcus viridans&nbsp;</em>group</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Actinobacillus actinomycetemcomitans</em></p><p><em>Capnocytophaga&nbsp;</em>spp.</p><p><em>Eikenella corrodens</em></p><p><em>Haemophilus influenzae</em><sup>2</sup></p><p><em>Moraxella catarrhalis</em></p><p><em>Neisseria gonorrhoeae</em>&sect;</p><p><em>Pasteurella multocida</em></p><p><u>Anaerobic micro-organisms</u></p><p><em>Bacteroides fragilis</em></p><p><em>Fusobacterium nucleatum</em></p><p><em>Prevotella</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Species for which acquired resistance may be a problem</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecium&nbsp;</em>$</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Escherichia coli</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Proteus mirabilis</em></p><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Inherently resistant organisms</u></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Acinetobacter&nbsp;</em>sp.</p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter</em>&nbsp;sp.</p><p><em>Legionella pneumophila</em></p><p><em>Morganella morganii</em></p><p><em>Providencia&nbsp;</em>spp.</p><p><em>Pseudomonas&nbsp;</em>sp.</p><p><em>Serratia&nbsp;</em>sp.</p><p><em>Stenotrophomonas maltophilia</em></p><p><u>Other micro-organisms</u></p><p><em>Chlamydia trachomatis</em></p><p><em>Chlamydophila pneumoniae</em></p><p><em>Chlamydophila psittaci</em></p><p><em>Coxiella burnetti</em></p><p><em>Mycoplasma pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p>$ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.</p><p>&pound; All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid.</p><p>&sect; All strains with resistance to amoxicillin that is not mediated by beta-lactamases are resistant to amoxicillin/clavulanic acid.</p><p><sup>1</sup>&nbsp;This presentation of amoxicillin/clavulanic acid may not be suitable for treatment of&nbsp;<em>Streptococcus pneumoniae</em>&nbsp;that are resistant to penicillin (see sections 4.2 and 4.4).</p><p><sup>2&nbsp;</sup>Strains with decreased susceptibility have been reported in some countries in the EU with a frequency higher than 10%.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>The pharmacokinetic results for studies in which amoxicillin/clavulanic acid was administered to groups of healthy volunteers as either 500 mg/100 mg or 1000 mg/200 mg given as a bolus intravenous injection are presented below.</p><table border="1" cellspacing="0" cellpadding="0" style="width:501px"><tbody><tr><td colspan="6" style="vertical-align:top"><p>Mean (&plusmn;SD) pharmacokinetic parameters</p><p><em>Bolus intravenous injection</em></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Dose administered</p></td><td colspan="5" style="vertical-align:top"><p>Amoxicillin</p></td></tr><tr><td style="vertical-align:top"><p>Dose</p></td><td style="vertical-align:top"><p>Mean peak serum conc (&mu;g/ml)</p></td><td style="vertical-align:top"><p>T 1/2 (h)</p></td><td style="vertical-align:top"><p>AUC (h.mg/l)</p></td><td style="vertical-align:top"><p>Urinary recovery (%, 0 to 6 h)</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 500 mg/100 mg</p></td><td style="vertical-align:top"><p>500 mg</p></td><td style="vertical-align:top"><p>32.2</p></td><td style="vertical-align:top"><p>1.07</p></td><td style="vertical-align:top"><p>25.5</p></td><td style="vertical-align:top"><p>66.5</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 1000 mg/200 mg</p></td><td style="vertical-align:top"><p>1000 mg</p></td><td style="vertical-align:top"><p>105.4</p></td><td style="vertical-align:top"><p>0.9</p></td><td style="vertical-align:top"><p>76.3</p></td><td style="vertical-align:top"><p>77.4</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td colspan="5" style="vertical-align:top"><p>Clavulanic acid</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 500 mg/100 mg</p></td><td style="vertical-align:top"><p>100 mg</p></td><td style="vertical-align:top"><p>10.5</p></td><td style="vertical-align:top"><p>1.12</p></td><td style="vertical-align:top"><p>9.2</p></td><td style="vertical-align:top"><p>46.0</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 1000 mg/200 mg</p></td><td style="vertical-align:top"><p>200 mg</p></td><td style="vertical-align:top"><p>28.5</p></td><td style="vertical-align:top"><p>0.9</p></td><td style="vertical-align:top"><p>27.9</p></td><td style="vertical-align:top"><p>63.8</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>AMX &ndash; amoxicillin, CA &ndash; clavulanic acid</p></td></tr></tbody></table><p><strong><u>Distribution</u></strong></p><p>About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to protein. The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around 0.2 l/kg for clavulanic acid.</p><p>Following intravenous administration, both amoxicillin and clavulanic acid have been found in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material for either component. Amoxicillin, like most penicillins, can be detected in breast milk. Trace quantities of clavulanic acid can also be detected in breast milk (see section 4.6).</p><p><u>Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see section 4.6).</u></p><p>&nbsp;</p><p><strong><u>Biotransformation</u></strong></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized in man, and eliminated in urine and faeces and as carbon dioxide in expired air.</p><p><strong><u>Elimination</u></strong></p><p>The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid it is by both renal and non-renal mechanisms.</p><p>Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of a single 500/100 mg or a single 1000/200 mg bolus intravenous injection. Various studies have found the urinary excretion to be 50-85% for amoxicillin and between 27-60% for clavulanic acid over a 24 hour period. In the case of clavulanic acid, the largest amount of drug is excreted during the first 2 hours after administration.</p><p>Concomitant use of probenecid delays amoxicillin excretion but does not delay renal excretion of clavulanic acid (see section 4.5).</p><p><strong><u>Age</u></strong></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults. For very young children (including preterm newborns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p><p><strong><u>Renal impairment</u></strong></p><p>The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with decreasing renal function. The reduction in drug clearance is more pronounced for amoxicillin than for clavulanic acid, as a higher proportion of amoxicillin is excreted&nbsp;<em>via&nbsp;</em>the renal route. Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).</p><p><strong><u>Hepatic impairment</u></strong></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on studies of safety pharmacology, genotoxicity and toxicity to reproduction.</p><p>Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid demonstrate gastric irritancy and vomiting, and discoloured tongue.</p><p>Carcinogenicity studies have not been conducted with amoxicillin/clavulanic acid or its components.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</p><p><strong>Julmentin</strong> Intravenous should not be mixed with blood products, other proteinaceous fluids such as protein hydrolysates or with intravenous lipid emulsions. If prescribed concomitantly with an aminoglycoside, the antibiotics should not be mixed in the syringe, intravenous fluid container or giving set because loss of activity of the aminoglycoside can occur under these conditions.</p><p><strong>Julmentin</strong> solutions should not be mixed with infusions containing glucose, dextran or bicarbonate.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; Before reconstitution, do not store above 25&deg;C, protect from light and heat.&nbsp;</p><p>&sect; After reconstitution, use immediately. Do not freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; Clear glass vial with a printed label, 1 vial packed in a printed carton along with a leaflet.</p><p>&sect; Clear glass vial with a printed label, 10 vials packed in a printed box along with a leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Reconstitution and Administration</strong></p><p><strong>Julmentin</strong> may be administered either by intravenous injection or by intermittent infusion. It is not suitable for intramuscular administration.</p><p>For reconstitution, add 10mL of sterile water for injection to the contents of 0.6g vial.</p><p>The stability of <strong>Julmentin</strong> solution is concentration dependent thus for:</p><p><strong><u>Intravenous Injection</u></strong></p><p><strong>Julmentin</strong> should be used immediately upon reconstitution and given by slow intravenous injection over a period of 3 - 5 minutes. <strong>Julmentin</strong> may be injected directly into a vein or via a drip tube.</p><p><strong><u>Intravenous Infusion</u></strong></p><p><strong>Julmentin</strong> may be infused in water for Injection or Sodium Chloride Intravenous Injection (0.9% w/v). Add 0.6g reconstituted solution to 50mL infusion fluid. Infuse over 30-40 minutes immediately after reconstitution.</p><p>Any residual antibiotic solutions should be discarded.</p><p><strong>Stability in IV Fluid</strong></p><p>Intravenous infusion of <strong>Julmentin</strong> may be given in a range of different intravenous fluids. Satisfactory antibiotic concentrations are retained at 5&deg;C and at room temperature 25<sup>o</sup>C in the recommended volumes of the following infusion fluids. If reconstituted and maintained at room temperature, infusions should be completed within the times stated.</p><p>Reconstituted solutions should not be frozen.</p><table border="1" cellspacing="0" cellpadding="0" style="width:540px"><tbody><tr><td style="vertical-align:top"><p><strong>Intravenous infusion Fluids</strong></p></td><td style="vertical-align:top"><p><strong>Stability Period at 25&deg;C</strong></p></td></tr><tr><td style="vertical-align:top"><p>Water for Injections</p></td><td style="vertical-align:top"><p>4 hours</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride Intravenous Infusion (0.9% w/v)</p></td><td style="vertical-align:top"><p>4 hours</p></td></tr><tr><td style="vertical-align:top"><p>Lactated Ringer s intravenous infusion</p></td><td style="vertical-align:top"><p>3 hours</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride intravenous infusion (1M)</p></td><td style="vertical-align:top"><p>3 hours</p></td></tr><tr><td style="vertical-align:top"><p>Potassium Chloride intravenous infusion (1M)</p></td><td style="vertical-align:top"><p>3 hours</p></td></tr></tbody></table><p><strong>Julmentin</strong> is less stable in infusions containing glucose, dextran and bicarbonate. Reconstituted solutions of <strong>Julmentin </strong>should, therefore, not be added to such infusions but may be injected into the drip tubing over a period of 3 - 4 minutes.</p><p>For storage at 5&deg;C, the reconstituted solution should be added to pre-refrigerated infusion bags, which can be stored for up to 8 hours. Thereafter, the infusion should be administered immediately after reaching room temperature.</p><table border="1" cellspacing="0" cellpadding="0" style="width:540px"><tbody><tr><td style="vertical-align:top"><p><strong>Intravenous infusion Fluids</strong></p></td><td style="vertical-align:top"><p><strong>Stability Period at 5&deg;C</strong></p></td></tr><tr><td style="vertical-align:top"><p>Water for Injections</p></td><td style="vertical-align:top"><p>8 hours</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride Intravenous Infusion (0.9% w/v)</p></td><td style="vertical-align:top"><p>8 hours</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                20. May. 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>